| Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS (NCT05646394) | McMaster University | 2022-07-01 |
| Effect of Injectable Anticoagulants on Research for a Circulating Lupus-type Anticoagulant (NCT05416190) | University Hospital, Clermont-Ferrand | 2022-06-02 |
| The BeLimumab Antiphospholipid Syndrome Trial (BLAST) (NCT05020782) | University of Turin, Italy | 2022-06-01 |
| Prospective Observational Study to Evaluate a Possible Change in APS Antibody Profiles After COVID-19 Infection or Vaccination (NCT05313048) | Cardioangiologisches Centrum Bethanien | 2022-03-15 |
| Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia (NCT05199909) | Institute of Hematology & Blood Diseases Hospital, China | 2022-01-25 |
| Impact of Antiphospholipid Antibodies on Thrombin Generation During Sars-CoV2 Infection (TACIT2 Study) (NCT05128760) | Central Hospital, Nancy, France | 2022-01-01 |
| RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome (NCT03684564) | University College, London | 2021-07-09 |
| Laboratory and Clinical Data in Antiphospholipid Patients (NCT04308564) | Central Hospital, Nancy, France | 2021-04-12 |
| A Study of Hydroxychloroquine Sulfate in the Treatment of Recurrent Spontaneous Abortion With Antiphospholipid Syndrome (NCT04624269) | Shanghai First Maternity and Infant Hospital | 2020-12-01 |
| International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants (NCT04262492) | Stéphane Zuily | 2020-10-21 |
| Rheumatology Patient Registry and Biorepository (NCT04402086) | Yale University | 2020-08-04 |
| Monitoring the Antiphospholipid Syndrome:TOXicity of Drugs (APSTOX) (NCT03994302) | Groupe Hospitalier Pitie-Salpetriere | 2019-06-01 |
| New Biological Tests in Patients With Antiphospholipid Antibodies (NCT03890601) | Hospices Civils de Lyon | 2019-03-13 |
| Prevalence of Antiphospholipid Antibodies in the Hemodialysis Patients Population Within the CHU Brugmann Hospital (NCT03893357) | Brugmann University Hospital | 2019-03-01 |
| Evaluation of Precision and Accuracy of INR Measurements in a Point of Care Device (NCT03682419) | LumiraDx UK Limited | 2018-09-17 |
| Measurement of Anti-dsDNA by Both CLIFT & ELISA (NCT03303508) | Assiut University | 2018-09-01 |
| Multi-organ Screening for Asymptomatic Ischaemia in Antiphospholipid Syndrome (NCT03348306) | Central Hospital, Nancy, France | 2018-07-20 |
| Evaluation of the Incidence of Cancer in the Follow-up of Women With 3 Consecutive Embryonic Demises Before 10 Weeks or 1 Fetal Death, According to Their Thrombophilia Status, With a Special Focus on Women With an Obstetric Antiphospholipid Symdrome (oAPS) (NCT03969498) | Centre Hospitalier Universitaire de Nīmes | 2018-01-02 |
| Antiphospholipid Antibodies and Early Severe Preeclampsia. (NCT01538121) | Saint Thomas Hospital, Panama | 2015-06-01 |
| Pregnancy and Medically Assisted Conception in Rare Diseases (NCT02450396) | Assistance Publique - Hôpitaux de Paris | 2015-06-01 |
| Effectivity and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid Syndrome (NCT05195372) | Cardioangiologisches Centrum Bethanien | 2015-01-01 |
| Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome (NCT02295475) | Scott C. Woller, MD | 2014-12-10 |
| Timing of Initiation of LMWH Administration in Pregnant Women With APS (NCT02326051) | Mohamed Sayed Abdelhafez | 2014-12-01 |
| Rivaroxaban in Thrombotic Antiphospholipid Syndrome (NCT02157272) | University of Padova | 2014-12-01 |
| Use of Warfarin After the First Trimester in Pregnant Women With APS (NCT02303171) | Mohamed Sayed Abdelhafez | 2014-11-01 |
| Comparative Prevalence of Psychiatric Manifestations in Purely Obstetrical Antiphospholipid Syndrome (NCT01649479) | Centre Hospitalier Universitaire de Nīmes | 2013-04-01 |
| Rivaroxaban for Patients With Antiphospholipid Syndrome (NCT02926170) | Hospital Universitari Vall d'Hebron Research Institute | 2013-03-13 |
| The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome (NCT01818505) | National Taiwan University Hospital | 2013-03-01 |
| Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients (NCT01784523) | Hospital for Special Surgery, New York | 2013-02-01 |
| Hydroxychloroquine for Thrombosis Prevention and Antiphospholipid Antibody Reduction in Primary Antiphospholipid Syndrome (NCT04153201) | National and Kapodistrian University of Athens | 2013-01-15 |
| Monitoring Anticoagulant Therapy in Antiphospholipid Syndrome (NCT01660061) | Johann Wolfgang Goethe University Hospital | 2011-07-01 |
| Pharmacogenetics of Warfarin in Puerto Ricans. (NCT01318057) | University of Puerto Rico | 2011-02-01 |
| Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE) (NCT01475149) | Hospital for Special Surgery, New York | 2010-09-01 |
| Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases (NCT01151644) | University of Sao Paulo | 2010-04-01 |
| Reliability of Point-of-care INR Measurements in Patients With Antiphospholipid-antibody Syndrome Treated With Warfarin (NCT00878137) | University of North Carolina, Chapel Hill | 2009-03-01 |
| Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome Patients (NCT00674297) | Hospital for Special Surgery, New York | 2008-05-01 |
| A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome (NCT00537290) | Hospital for Special Surgery, New York | 2007-09-01 |
| Drug Interaction Between Paracetamol and Warfarin (NCT01104337) | Hopital Lariboisière | 2007-03-01 |
| Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study (NCT00616317) | University of California, Davis | 2006-09-01 |
| Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome (NCT00482794) | Duke University | 2006-06-01 |
| Steroids and Antiphospholipid Syndrome- Related Pregnancy Loss (NCT00180778) | Imperial College London | 2005-10-01 |
| Hematopoietic Stem Cell Transplantation in Patients With Antiphospholipid Syndrome (NCT00278616) | Richard Burt, MD | 2005-08-01 |
| Assessment of the Prevalence of Major Psychiatric Disorders in a Cohort of Women With Clinical Criteria Corresponding to Pure, Abortive-form, Obstetrical, Antiphospholipid Syndrome (NCT02833194) | Centre Hospitalier Universitaire de Nīmes | 2005-07-01 |
| The Prognostic Value of PGF and sFlt1 Variations Induced by the First Low-molecular-weight-heparin Injections in Women With Obstetrical Antiphospholipids Antibody Syndrome Starting a New Pregnancy and Following Treatment in Accordance With International Recommendations (NCT02855047) | Centre Hospitalier Universitaire de Nīmes | 2005-07-01 |
| Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS) (NCT00198068) | Hospital for Special Surgery, New York | 2003-09-01 |
| Antiphospholipid Syndrome Collaborative Registry (APSCORE) (NCT00076713) | University of North Carolina, Chapel Hill | 2000-04-01 |
| Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies. (NCT00180817) | Imperial College London | 1998-09-01 |